p53 Mutations in Locally Advanced Breast Cancers
Author Information
Author(s): A. Faille, P. De Cremoux, J.M. Extra, G. Linares, M. Espie, E. Bourstyn, A. De Rocquancourt, S. Giacchetti, M. Marty, F. Calvo
Primary Institution: Hopital Saint Louis, Paris, France
Hypothesis
What is the mutational pattern of p53 in locally advanced breast cancers and how does it relate to clinical outcomes?
Conclusion
p53 mutations are associated with larger tumor size and the presence of metastases in locally advanced breast cancers.
Supporting Evidence
- 16 out of 39 patients showed p53 mutations.
- p53 mutations were significantly associated with larger tumor diameter.
- Patients with p53 mutations had a higher rate of clinical metastases.
Takeaway
This study looked at breast cancer patients to see if changes in a gene called p53 were linked to bigger tumors and more spread of the cancer.
Methodology
The study analyzed p53 mutations using PCR-SSCP and immunohistochemistry in tumor samples from 39 patients with locally advanced breast cancer.
Limitations
The study was limited to a small, homogeneous group of patients and may not be generalizable to all breast cancer patients.
Participant Demographics
Patients were classified as having locally advanced breast cancer (stage III-IV), with a majority being inflammatory breast cancer (IBC) type.
Statistical Information
P-Value
0.0062
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website